Nestle India, Dr Reddy’s To Form Joint Venture For Nutraceutical Brands

Gurugram and Hyderabad: Nestlé India Limited referred hereafter as “Nestlé India” and Dr. Reddy’s Laboratories Ltd; along with its subsidiaries together referred to as “Dr. Reddy’s”), both together referred as “JV Partners”, today announced that they have entered into a definitive agreement to form a joint venture (“JV Company”) to bring innovative nutraceutical brands to consumers in India and other agreed territories. The partnership will bring together the well-known global range of nutritional health solutions as well as vitamin, minerals, herbals and supplements of Nestlé Health Science (NHSc) with the strong and established commercial strengths of Dr. Reddy’s in India. The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios in categories such as metabolic, hospital nutrition, general wellness , women’s health and child nutrition for consumers across India.

The JV Company will be headquartered in Hyderabad. The JV Company will leverage the capabilities as well as services of the Nestlé Group and Dr. Reddy’s.

Select brands will be licensed by the JV Partners to the JV company. The Nestlé Group will license brands such as Nature’s Bounty, Osteo Bi-Flex, Ester-C, Resource High Protein, Optifast, Resource Diabetic, Peptamen, Resource Renal and Resource Dialysis. Dr. Reddy’s will license brands such as Rebalanz, Celevida, Antoxid, Kidrich-D3, Becozinc in the nutrition, and OTC segments. The JV Company is expected to become operational in Q2 of FY’25.

Commenting on the joint venture, Mr. Suresh Narayanan, Chairman and Managing Director, Nestlé India said, “I am very happy to share that we are entering into a joint venture with Dr. Reddy’s Laboratories Ltd. We have been on a journey where we strive to add value to the lives of our consumers through powerful brands and products. This joint venture is another important step in that direction, allowing us to bring our science-backed nutritional solutions to more people across the country. Dr. Reddy’s is a trusted name in the pharmaceutical space and shares our commitment to provide access to high quality products. This joint venture will enable us to build a robust retail and distribution network to take our brands closer to consumers and making a meaningful difference to improve the quality of life.”

M.V. Ramana, CEO – Branded Markets (India & Emerging Markets), Dr. Reddy’s said, “This joint venture is a novel approach by two companies that have a shared purpose of good health. We are pleased to partner with Nestlé India to bring innovations from the Nestlé Health Science global portfolio to consumers in India. This novel approach of leveraging mutually complementary strengths of both parent companies will enable better access and affordability for consumers.”

Related Posts

18 maternal deaths still a ‘mystery’, says Rajasthan health minister

JAIPUR: Three months after Rajasthan first began reporting clusters of maternal fatalities at state-run hospitals, the govt has still no explanation so far of what caused the deaths of 18 women…

FDA suspends licence of Pune’s Metro Blood Bank; 10 district blood centres face action

FDA officials said the approved technical supervisor at the bank had resigned in March 2025, but blood component separation allegedly continued without an approved replacement. Pune: The Maharashtra Food and…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

18 maternal deaths still a ‘mystery’, says Rajasthan health minister

18 maternal deaths still a ‘mystery’, says Rajasthan health minister

FDA suspends licence of Pune’s Metro Blood Bank; 10 district blood centres face action

FDA suspends licence of Pune’s Metro Blood Bank; 10 district blood centres face action

Health Ministry Unveils Thalassemia Awareness Posters to Promote Early Screening

Health Ministry Unveils Thalassemia Awareness Posters to Promote Early Screening

Employees are Apples of ENTOD’s Eyes, few fall Far from Tree

Employees are Apples of ENTOD’s Eyes, few fall Far from Tree

After two years, pharma volumes pick up pace

After two years, pharma volumes pick up pace

NPPA fixes prices of 39 drugs, raises anti-rabies immunoglobulin rate

NPPA fixes prices of 39 drugs, raises anti-rabies immunoglobulin rate